Implantable Sensor Actuation to Prevent Tissue Ingrowth

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing implantable sensors face challenges with tissue ingrowth and endothelialization, leading to difficulties in chronic measurement accuracy and potential complications during removal, especially when used for central blood pressure monitoring.

Innovation Solution

Implantable sensors with dynamic stabilization features and actuation elements that periodically change position or configuration to reduce tissue ingrowth and endothelialization, combined with bioabsorbable materials and coatings to minimize adhesion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If implantable sensors are used for chronic measurement, then measurement duration is improved, but tissue ingrowth and endothelialization occur causing measurement accuracy to deteriorate

Engineering Contradiction:
Improvemeasurement durationVSAvoidmeasurement accuracy
Core Design Contradiction:
Duration of action of stationary objectVSMeasurement precision

Solution Approach 1:

The sensor assembly is made dynamically movable relative to the implant body through a mechanism including a biasing element and actuator. This allows periodic adjustment of the sensor position to prevent tissue ingrowth and endothelialization, thereby maintaining measurement accuracy over chronic durations without sacrificing long-term implantability

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The sensor assembly performs periodic movements or position changes driven by the actuator mechanism. These periodic actions disrupt tissue formation around the sensor, preventing the degradation of measurement accuracy that would otherwise occur during chronic implantation

Inventive Principle:
Principle #19Periodic action

2Duration of action of stationary object

If implantable sensors are used for chronic measurement, then measurement duration is improved, but sensor removal becomes difficult due to tissue adhesion

Engineering Contradiction:
Improvemeasurement durationVSAvoidsensor removal ease
Core Design Contradiction:
Duration of action of stationary objectVSEase of operation

Solution Approach 1:

The sensor assembly is designed as a separable component that can be extracted from the implant body. The movable connection mechanism allows the sensor to be detached and removed independently from the permanent implant, facilitating easy retrieval after chronic measurement without requiring removal of the entire implant system

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The dynamic movability of the sensor assembly prevents permanent adhesion to surrounding tissues during the measurement period. This maintains the sensor's extractability and enables straightforward removal after the chronic measurement objective is achieved

Inventive Principle:
Principle #15Dynamics

3Stability of the object's composition

If sensors are stabilized firmly in position, then measurement stability is improved, but tissue ingrowth increases making removal difficult

Engineering Contradiction:
Improvemeasurement stabilityVSAvoidsensor removal ease
Core Design Contradiction:
Stability of the object's compositionVSEase of operation

Solution Approach 1:

Rather than firm stabilization, the system employs controlled dynamic movement to maintain measurement stability. The actuator-driven position adjustments prevent tissue ingrowth while preserving the ability to remove the sensor, achieving both stability and removability through periodic repositioning rather than fixed anchoring

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS20260083946A1Implantable sensors and associated systems and methods
Publication Date: 2026.03.26 SHIFAMED HLDG LLC
  • US20260083946A1 patent drawing
  • US20260083946A1 patent drawing
  • US20260083946A1 patent drawing

AI summary

The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes a system for shunting blood between a left atrium and a right atrium of a patient. The system can include a shunting element having a lumen extending therethrough. The lumen is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in the patient. The system can also include a sensor configured to be implanted in the patient and operably coupled to the shunting element. An actuation element is coupled to the sensor. The actuation element is configured to be selectively energized and transmit a desired motion to the sensor to reduce the likelihood of tissue ingrowth/overgrowth and adhesion on at least a portion of the sensor.